|
|
Article: Geron Reports Grant of European Cloning Patent and Forms Business Unit to Commercialize Nuclear Transfer Technology.
- Article from:
- Business Wire
- Article date:
- February 15, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors and Health/Medical Writers
MENLO PARK, Calif.--(BW HealthWire)--Feb. 15, 2001
Geron Corporation (Nasdaq:GERN) announced today that the European Patent Office has granted European Patent No. 0849990, "Quiescent Cell Populations for Nuclear Transfer," which covers the use of nuclear transfer technology to clone non-human animals, including cows, pigs, sheep, goats, chickens and other species.
"The granting of this European Patent extends our nuclear transfer patent coverage into other important markets," said David J. Earp, J.D., Ph.D., Geron's vice president of intellectual property. Patents for this technology platform have ...